8213 results for "canc*"

in 41.24 milliseconds.

• Genome and transcriptome sequence data from a locally advanced (cutaneous) melanoma patient

  Genome and transcriptome sequence data from a locally advanced (cutaneous) melanoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016688

• Genome and transcriptome sequence data from a denovo metastatic triple negative breast cancer patient

  Genome and transcriptome sequence data from a denovo metastatic triple negative breast cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016689

• Genome and transcriptome sequence data from a metastatic breast cancer patient

  Genome and transcriptome sequence data from a metastatic breast cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016690

• Genome and transcriptome sequence data from a metastatic mucinous adenocarcinoma of the cecum patient

  Genome and transcriptome sequence data from a metastatic mucinous adenocarcinoma of the cecum patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016691

• Genome and transcriptome sequence data from a hairy cell leukemia patient

  Genome and transcriptome sequence data from a hairy cell leukemia patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016692

• Genome and transcriptome sequence data from a metastatic triple negative breast cancer to liver (ductal) patient

  Genome and transcriptome sequence data from a metastatic triple negative breast cancer to liver (ductal) patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016693

• Genome and transcriptome sequence data from a metastatic dedifferentiated liposarcoma patient

  Genome and transcriptome sequence data from a metastatic dedifferentiated liposarcoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016694

• Genome and transcriptome sequence data from a metastatic chordoma mets to lung patient

  Genome and transcriptome sequence data from a metastatic chordoma mets to lung patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016695

• Genome and transcriptome sequence data from a recurrent pancreatic head ductal adenocarcinoma patient

  Genome and transcriptome sequence data from a recurrent pancreatic head ductal adenocarcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016696

• Genome and transcriptome sequence data from a metastatic left thigh undifferentiated pleomorphic sarcoma patient

  Genome and transcriptome sequence data from a metastatic left thigh undifferentiated pleomorphic sarcoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016697

• Genome and transcriptome sequence data from a ovarian clear cell carcinoma of the bilateral ovary patient

  Genome and transcriptome sequence data from a ovarian clear cell carcinoma of the bilateral ovary patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016698

• Genome and transcriptome sequence data from a squamous cell carcinoma of vulva hpv independent patient

  Genome and transcriptome sequence data from a squamous cell carcinoma of vulva hpv independent patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016699

• Genome and transcriptome sequence data from a metastatic squamous cell lung cancer patient

  Genome and transcriptome sequence data from a metastatic squamous cell lung cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016700

• Genome and transcriptome sequence data from a metastatic small cell neuroendocrine of left renal pelvis patient

  Genome and transcriptome sequence data from a metastatic small cell neuroendocrine of left renal pelvis patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016701

• Genome and transcriptome sequence data from a metastatic ampullary adenocarcinoma pancreaticobiliary subtype patient

  Genome and transcriptome sequence data from a metastatic ampullary adenocarcinoma pancreaticobiliary subtype patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016702

• Genome and transcriptome sequence data from a metastatic gastroesophageal cancer patient

  Genome and transcriptome sequence data from a metastatic gastroesophageal cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016703

• Genome and transcriptome sequence data from a epithelioid hemangioendothelioma patient

  Genome and transcriptome sequence data from a epithelioid hemangioendothelioma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016704

• Genome and transcriptome sequence data from a metastatic colon cancer patient

  Genome and transcriptome sequence data from a metastatic colon cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016705

• Genome and transcriptome sequence data from a diffuse glioma patient

  Genome and transcriptome sequence data from a diffuse glioma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016706

• Genome and transcriptome sequence data from a metastatic clear cell ovarian cancer patient

  Genome and transcriptome sequence data from a metastatic clear cell ovarian cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016707

• Genome and transcriptome sequence data from a metastatic cholangiocarcinoma patient

  Genome and transcriptome sequence data from a metastatic cholangiocarcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016708

• Genome and transcriptome sequence data from a metastatic colorectal cancer patient

  Genome and transcriptome sequence data from a metastatic colorectal cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016709

• Genome and transcriptome sequence data from a metastatic right hemipelvis undifferentiated pleomorphic sarcoma of bone, metastatic disease to bilateral lung patient

  Genome and transcriptome sequence data from a metastatic right hemipelvis undifferentiated pleomorphic sarcoma of bone, metastatic disease to bilateral lung patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016710

• Genome and transcriptome sequence data from a metastatic leiomyosarcoma patient

  Genome and transcriptome sequence data from a metastatic leiomyosarcoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016711

• Genome and transcriptome sequence data from a intra-parotid scc, p16 negative, primary unknown, skin versus parotid primary patient

  Genome and transcriptome sequence data from a intra-parotid scc, p16 negative, primary unknown, skin versus parotid primary patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016712

• Genome and transcriptome sequence data from a pleomorphic dermal sarcoma of the right proximal thigh, recurrent to lung patient

  Genome and transcriptome sequence data from a pleomorphic dermal sarcoma of the right proximal thigh, recurrent to lung patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016713

• Genome and transcriptome sequence data from a metastatic high grade poorly differentiated papillary thyroid cancer patient

  Genome and transcriptome sequence data from a metastatic high grade poorly differentiated papillary thyroid cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016714

• Genome and transcriptome sequence data from a thymic carcinoma with metastasis patient

  Genome and transcriptome sequence data from a thymic carcinoma with metastasis patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016715

• Genome and transcriptome sequence data from a recurrent glioblastoma patient

  Genome and transcriptome sequence data from a recurrent glioblastoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016716

• Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient

  Genome and transcriptome sequence data from a pancreatic adenocarcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016717

• Genome and transcriptome sequence data from a advanced high-grade serous endometrial carcinoma patient

  Genome and transcriptome sequence data from a advanced high-grade serous endometrial carcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016718

• Genome and transcriptome sequence data from a metastatic oncocytic thyroid patient

  Genome and transcriptome sequence data from a metastatic oncocytic thyroid patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016719

• Genome and transcriptome sequence data from a metastatic renal cell carcinoma patient

  Genome and transcriptome sequence data from a metastatic renal cell carcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016720

• Genome and transcriptome sequence data from a squamous cell carcinoma of the nasopharynx p16+, eber neg patient

  Genome and transcriptome sequence data from a squamous cell carcinoma of the nasopharynx p16+, eber neg patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016721

• Genome and transcriptome sequence data from a uterine leiomyosarcoma patient

  Genome and transcriptome sequence data from a uterine leiomyosarcoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016722

• Genome and transcriptome sequence data from a denovo metastatic hr+ her2- breast cancer (ductal) patient

  Genome and transcriptome sequence data from a denovo metastatic hr+ her2- breast cancer (ductal) patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016723

• Genome and transcriptome sequence data from a right-sided squamous cell carcinoma of the neck, pharyngeal region and base of skull patient

  Genome and transcriptome sequence data from a right-sided squamous cell carcinoma of the neck, pharyngeal region and base of skull patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016724

• Genome and transcriptome sequence data from a metastatic colorectal adenocarcinoma patient

  Genome and transcriptome sequence data from a metastatic colorectal adenocarcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016725

• Genome and transcriptome sequence data from a metastatic er+ her2 low breast cancer to pleura, bone, supraclavicular node (ductal) patient

  Genome and transcriptome sequence data from a metastatic er+ her2 low breast cancer to pleura, bone, supraclavicular node (ductal) patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016726

• Genome and transcriptome sequence data from a recurrent renal cell carcinoma patient

  Genome and transcriptome sequence data from a recurrent renal cell carcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016727

• Genome and transcriptome sequence data from a uterine leiomyosarcoma patient

  Genome and transcriptome sequence data from a uterine leiomyosarcoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016466

• Genome and transcriptome sequence data from a undifferentiated uterine sarcoma patient

  Genome and transcriptome sequence data from a undifferentiated uterine sarcoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016467

• Genome and transcriptome sequence data from a mesonephric like adenocarcinoma of the endometrium patient

  Genome and transcriptome sequence data from a mesonephric like adenocarcinoma of the endometrium patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016468

• Genome and transcriptome sequence data from a recurrent clear cell carcinoma of the ovary patient

  Genome and transcriptome sequence data from a recurrent clear cell carcinoma of the ovary patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016469

• Genome and transcriptome sequence data from a recurrent squamous cell carcinoma of the larynx patient

  Genome and transcriptome sequence data from a recurrent squamous cell carcinoma of the larynx patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016470

• Genome and transcriptome sequence data from a recurrent right tongue squamous cell carcinoma patient

  Genome and transcriptome sequence data from a recurrent right tongue squamous cell carcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016471

• Genome and transcriptome sequence data from a metastatic leiomyosarcoma of the uterine origin patient

  Genome and transcriptome sequence data from a metastatic leiomyosarcoma of the uterine origin patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016472

• Genome and transcriptome sequence data from a metastatic undifferentiated pleomorphic sarcoma patient

  Genome and transcriptome sequence data from a metastatic undifferentiated pleomorphic sarcoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016473

• Genome and transcriptome sequence data from a secondary malignant histiocytosis sarcoma transdifferentiated from follicular lymphoma patient

  Genome and transcriptome sequence data from a secondary malignant histiocytosis sarcoma transdifferentiated from follicular lymphoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016474

• Genome and transcriptome sequence data from a metastatic breast cancer patient

  Genome and transcriptome sequence data from a metastatic breast cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016475

• Genome and transcriptome sequence data from a metastatic renal cell carcinoma patient

  Genome and transcriptome sequence data from a metastatic renal cell carcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016476

• Genome and transcriptome sequence data from a metastatic triple negative breast cancer patient

  Genome and transcriptome sequence data from a metastatic triple negative breast cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016477

• Genome and transcriptome sequence data from a metastatic undifferentiated pleomorphic sarcoma patient

  Genome and transcriptome sequence data from a metastatic undifferentiated pleomorphic sarcoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016478

• Genome and transcriptome sequence data from a metastatic pancreatic ductal adenocarcinoma patient

  Genome and transcriptome sequence data from a metastatic pancreatic ductal adenocarcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016479

• Genome and transcriptome sequence data from a metastatic adenocarcinoma of the lung patient

  Genome and transcriptome sequence data from a metastatic adenocarcinoma of the lung patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016480

• Genome and transcriptome sequence data from a lung leiomyosarcoma patient

  Genome and transcriptome sequence data from a lung leiomyosarcoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016481

• Genome and transcriptome sequence data from a metastatic colorectal cancer patient

  Genome and transcriptome sequence data from a metastatic colorectal cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016482

• Genome and transcriptome sequence data from a diseased patient

  Genome and transcriptome sequence data from a diseased patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016483

• Genome and transcriptome sequence data from a metastatic invasive ductal carcinoma of left breast patient

  Genome and transcriptome sequence data from a metastatic invasive ductal carcinoma of left breast patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016484

• Genome and transcriptome sequence data from a thymoma patient

  Genome and transcriptome sequence data from a thymoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016485

• Genome and transcriptome sequence data from a metastatic breast cancer patient

  Genome and transcriptome sequence data from a metastatic breast cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016486

• Genome and transcriptome sequence data from a metastatic hilar cholangiocarcinoma patient

  Genome and transcriptome sequence data from a metastatic hilar cholangiocarcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016488

• Genome and transcriptome sequence data from a metastatic breast cancer patient

  Genome and transcriptome sequence data from a metastatic breast cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016489

• Genome and transcriptome sequence data from a colon cancer patient

  Genome and transcriptome sequence data from a colon cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016490

• Genome and transcriptome sequence data from a small bowel neuroendocrine tumors patient

  Genome and transcriptome sequence data from a small bowel neuroendocrine tumors patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016491

• Genome and transcriptome sequence data from a metastatic well-differentiated neuroendocrine tumour patient

  Genome and transcriptome sequence data from a metastatic well-differentiated neuroendocrine tumour patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016492

• Genome and transcriptome sequence data from a vaginal/cervical leiomyosarcoma patient

  Genome and transcriptome sequence data from a vaginal/cervical leiomyosarcoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016493

• Genome and transcriptome sequence data from a uterine leiomyosarcoma patient

  Genome and transcriptome sequence data from a uterine leiomyosarcoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016494

• Genome and transcriptome sequence data from a pulmonary artery intimal sarcoma patient

  Genome and transcriptome sequence data from a pulmonary artery intimal sarcoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016495

• Genome and transcriptome sequence data from a nasopharyngeal carcinoma patient

  Genome and transcriptome sequence data from a nasopharyngeal carcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016496

• Genome and transcriptome sequence data from a rectal adenocarcinoma patient

  Genome and transcriptome sequence data from a rectal adenocarcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016497

• Genome and transcriptome sequence data from a transverse colon adenocarcinoma patient

  Genome and transcriptome sequence data from a transverse colon adenocarcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016498

• Genome and transcriptome sequence data from a metastatic colorectal cancer patient

  Genome and transcriptome sequence data from a metastatic colorectal cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016499

• Genome and transcriptome sequence data from a mesothelioma patient

  Genome and transcriptome sequence data from a mesothelioma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016500

• Genome and transcriptome sequence data from a gastric cancer patient

  Genome and transcriptome sequence data from a gastric cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016501

• Genome and transcriptome sequence data from a sigmoid cancer patient

  Genome and transcriptome sequence data from a sigmoid cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016502

• Genome and transcriptome sequence data from a metastatic cervical cancer patient

  Genome and transcriptome sequence data from a metastatic cervical cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016503

• Genome and transcriptome sequence data from a metastatic osteosarcoma patient

  Genome and transcriptome sequence data from a metastatic osteosarcoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016504

• Genome and transcriptome sequence data from a low grade serous ovarian carcinoma patient

  Genome and transcriptome sequence data from a low grade serous ovarian carcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016505

• Genome and transcriptome sequence data from a metastatic colorectal cancer patient

  Genome and transcriptome sequence data from a metastatic colorectal cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016506

• Genome and transcriptome sequence data from a metastatic colorectal cancer patient

  Genome and transcriptome sequence data from a metastatic colorectal cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016511

• Genome and transcriptome sequence data from a gastrointestinal clear cell sarcoma/jejunal malignant gastrointestinal neuroectodermal tumor patient

  Genome and transcriptome sequence data from a gastrointestinal clear cell sarcoma/jejunal malignant gastrointestinal neuroectodermal tumor patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016507

• Genome and transcriptome sequence data from a metastatic colorectal cancer patient

  Genome and transcriptome sequence data from a metastatic colorectal cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016508

• Genome and transcriptome sequence data from a metastatic colorectal adenocarcinoma patient

  Genome and transcriptome sequence data from a metastatic colorectal adenocarcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016509

• Genome and transcriptome sequence data from a metastatic colorectal cancer patient

  Genome and transcriptome sequence data from a metastatic colorectal cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016510

• Genome and transcriptome sequence data from a metastatic papillary thyroid cancer patient

  Genome and transcriptome sequence data from a metastatic papillary thyroid cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016512

• Genome and transcriptome sequence data from a metastatic nasopharyngeal cancer patient

  Genome and transcriptome sequence data from a metastatic nasopharyngeal cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016513

• Genome and transcriptome sequence data from a pancreatic neuroendocrine tumour patient

  Genome and transcriptome sequence data from a pancreatic neuroendocrine tumour patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016514

• Genome and transcriptome sequence data from a triple negative breast cancer patient

  Genome and transcriptome sequence data from a triple negative breast cancer patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016515

• Genome and transcriptome sequence data from a bilobar hepatocellular carcinoma patient

  Genome and transcriptome sequence data from a bilobar hepatocellular carcinoma patient,generated as part of the BC Cancer Agency's Personalized OncoGenomics (POG) study

  Dataset EGAD00001016516

• Leiomyosarcoma Cancer Transcriptome Sequencing

  RNA-Seq data (fastq raw read sequences) for French ICGC leiomyosarcoma cancer sequencing project, 78 samples representing 67 donors. Sequencing was performed on Illumina HiSeq. The libraries were then sequenced with a 2 x 75bp paired-end protocol to a minimum mean reads of 50 million.

  Dataset EGAD00001003192

• Constit Genome Sequencing

  WGS blood data (fastq raw read sequences) for French ICGC leiomyosarcoma cancer sequencing project, 67 samples representing 67 donors. Sequencing was performed on Illumina HiSeq. The libraries were then sequenced with a 2 x 100bp paired-end protocol to a minimum mean coverage of 30x.

  Dataset EGAD00001003190

• Leiomyosarcoma Cancer Genome Sequencing

  WGS cancer data (fastq raw read sequences) for French ICGC leiomyosarcoma cancer sequencing project, 78 samples representing 67 donors. Sequencing was performed on Illumina HiSeq. The libraries were then sequenced with a 2 x 100bp paired-end protocol to a minimum mean coverage of 50x.

  Dataset EGAD00001003191

• TRACERx NSCLC, multiregion sequencing of the first 100 tumors

  BACKGROUND TRACERx (TRAcking Cancer Evolution through therapy (Rx)) is a prospective cohort study designed to investigate intratumor heterogeneity (ITH) in relation to clinical outcome, and to determine the clonal nature of driver events and evolutionary processes in early stage non-small cell lung cancer (NSCLC). METHODS Multiregion high-depth whole-exome sequencing (M-seq) was performed on 100 early stage NSCLC tumors resected prior to systemic therapy. A total of 327 tumor regions were sequenced and analyzed to define evolutionary histories, obtain a census of clonal and subclonal events, and assess the relationship between ITH and recurrence-free survival (RFS). RESULTS Widespread ITH was observed for both somatic copy number alterations (median 48% [0.03-88%]) and mutations (median 30% [0.5-93%]). Driver mutations in EGFR, MET, BRAF and TP53 were almost always clonal. However, heterogeneous driver alterations occurring later in evolution were found in over 75% of tumors and were common in PIK3CA, NF1 and genes involved in chromatin modification and DNA response and repair. Genome doubling and ongoing dynamic chromosomal instability (CIN), illustrated by mirrored subclonal allelic imbalance, were identified as causes of ITH resulting in parallel evolution of driver copy number events, including amplifications of CDK4, FOXA1, and BCL11A. Elevated copy number heterogeneity was associated with shorter RFS (HR=4.9, P=0.00044), which remained significant in a multivariate analysis. CONCLUSIONS ITH mediated through CIN, rather than point mutational heterogeneity, was associated with increased risk of relapse, supporting its value as a prognostic predictor, and the need to target this high-risk phenotype.

  Dataset EGAD00001003206

• The molecular landscape of colorectal cancer reveals genetic mutations（5 cases）

  We collected tumor samples and adjacent nomal mucosae from 5 patients with colorectal cancer in surgical operation from 2014 to 2016 in the First Affiliated Hospital of Chongqing Medical University (Chongqing, China) and the Research Institute of Surgery, Third Military Medical University (Chongqing, China). the qualified captured library of each sample was then loaded on Illumina HiSeq 2000 (Illumina, San Diego, CA) platforms and subjected to high-throughput sequencing.

  Dataset EGAD00001003223

• There are 80 Brain cancer cases in this study and belong to GBM-CN project.

  There are 80 Brain cancer cases （160 samples）in this study and belong to GBM-CN project.

  Dataset EGAD00001003218

• The molecular landscape of colorectal cancer reveals genetic mutations（17 cases）

  We collected tumor samples and adjacent nomal mucosae from 17 patients with colorectal cancer in surgical operation from 2014 to 2016 in the First Affiliated Hospital of Chongqing Medical University (Chongqing, China) and the Research Institute of Surgery, Third Military Medical University (Chongqing, China). the qualified captured library of each sample was then loaded on Illumina HiSeq 2000 (Illumina, San Diego, CA) platforms and subjected to high-throughput sequencing.

  Dataset EGAD00001003224

• Batches 4-6 prostatectomy analysis

  Whole Genome Sequencing Illumina HiSeq data from 111 men with prostate cancer. Samples were taken from primary tissue obtained at prostatectomy (target sequencing depth 50X) with matched blood control (target sequencing depth 30X). This data is from batches 4 to 6.

  Dataset EGAD00001003225

• Global Anaplastic Thyroid Cancer Initiative

  Raw exome sequence data(fastq) for the GATCI project

  Dataset EGAD00001003235

• Global Anaplastic Thyroid Cancer Initiative

  Raw whole genome sequence data(fastq) for the GATCI project

  Dataset EGAD00001003236